medmix AG Total Liabilities
medmix AG total liabilities. Based on the latest financial reports, medmix AG (MEDX) has total liabilities worth CHF536.50 Million CHF (≈ $678.28 Million USD) as of December 2025. Total liabilities represent everything the company owes to external parties, combining both current liabilities—like accounts payable, short-term debt, and accrued expenses—and non-current liabilities such as long-term debt, pension obligations, lease liabilities, and deferred tax liabilities. Check MEDX cash and liquid asset ratio to evaluate the company's liquid asset resilience ratio.
Total Liabilities of medmix AG (2018–2025)
Total liabilities of medmix AG from 2018 to 2025. This chart illustrates how medmix AG's total liabilities have evolved over time, based on quarterly financial data.
medmix AG Competitors by Total Liabilities
The table below lists competitors of medmix AG ranked by their total liabilities.
| Company | Country | Total Liabilities |
|---|---|---|
|
Jing Jin Electric Technologies Co Ltd
SHG:688280
|
China | CN¥2.42 Billion |
|
Bank Bukopin Tbk
JK:BBKP
|
Indonesia | Rp78.54 Trillion |
|
Lanpec Technologies Ltd
SHG:601798
|
China | CN¥1.29 Billion |
|
CapsoVision, Inc. Common Stock
NASDAQ:CV
|
USA | $5.40 Million |
|
Third Point Investors Limited
LSE:TPOU
|
UK | $2.02 Million |
|
Atria Oyj A
HE:ATRAV
|
Finland | €562.70 Million |
|
Annil Co Ltd
SHE:002875
|
China | CN¥433.86 Million |
|
Focus Minerals Ltd
AU:FML
|
Australia | AU$74.65 Million |
Liability Composition Analysis (2018–2025)
This chart breaks down medmix AG's total liabilities into key components over time: long-term debt, short-term debt, other current liabilities, and other non-current liabilities. Toggle between absolute values and percentage view to see how the composition has shifted. For the complete balance sheet picture, see medmix AG total assets.
Liquidity & Leverage Metrics
medmix AG Total Liabilities Ratios Explained
medmix AG total liabilities ratios compare its liabilities with its current assets, cash and shareholder equity.
| Metric | Value | Description |
|---|---|---|
| Current Ratio | 1.54 | Measures ability to pay short-term obligations (Current Assets ÷ Current Liabilities) |
| Quick Ratio | N/A | More stringent measure of short-term liquidity ((Current Assets - Inventory) ÷ Current Liabilities) |
| Cash Ratio | 0.61 | Most conservative liquidity measure (Cash & Equivalents ÷ Current Liabilities) |
| Debt to Equity | 1.26 | Measures financial leverage (Total Liabilities ÷ Shareholder Equity) |
| Debt to Assets | 0.55 | Portion of assets financed with debt (Total Liabilities ÷ Total Assets) |
Liability Trends Comparison
This chart compares key liability metrics across different time periods, showing how medmix AG's debt structure has evolved. The comparison includes total liabilities, long-term debt, and current liabilities.
Annual Total Liabilities for medmix AG (2018–2025)
The table below shows the annual total liabilities of medmix AG from 2018 to 2025.
| Year | Total Liabilities | Change |
|---|---|---|
| 2025-12-31 | CHF536.50 Million ≈ $678.28 Million |
+5.71% |
| 2024-12-31 | CHF507.50 Million ≈ $641.62 Million |
-4.68% |
| 2023-12-31 | CHF532.40 Million ≈ $673.10 Million |
-11.43% |
| 2022-12-31 | CHF601.10 Million ≈ $759.95 Million |
+36.46% |
| 2021-12-31 | CHF440.50 Million ≈ $556.91 Million |
-3.50% |
| 2020-12-31 | CHF456.50 Million ≈ $577.14 Million |
+13.59% |
| 2019-12-31 | CHF401.90 Million ≈ $508.11 Million |
+6.21% |
| 2018-12-31 | CHF378.40 Million ≈ $478.40 Million |
-- |
About medmix AG
medmix AG designs, produces, and sells high-precision devices and services in Switzerland and internationally. It operates through the Healthcare, and Consumer and Industrial segments. The company offers dispensers, cartridges, mixers, tips, syringes, pen, and auto injectors for delivery of dental materials; delivery devices and mixing for bone repair and tissue treatment, which are used for pros… Read more